‹ go back

13th September 2018 – On World Sepsis Day, SENSIUM are delighted to share a publication concluding that patients presenting evidence of sepsis and receiving continuous monitoring with the Sensium patch were administered antibiotics faster

A recent publication evaluated whether continuous remote vital signs monitoring is a practical, acceptable and effective way of monitoring surgical patients.

A cluster-randomised, controlled study was performed with patients admitted to two surgical wards at a large tertiary hospital. Patients received either continuous and intermittent vital signs monitoring, or intermittent monitoring alone. The primary outcome measure was time to administration of antibiotics in sepsis. 350 patients were recruited (January - June 2017), 140 patients received continuous remote monitoring and 210 received intermittent monitoring alone.

One of the key findings from the study was that on average, patients presenting evidence of sepsis and receiving continuous monitoring were administered antibiotics faster than the control group.

Dr Ron Daniels, BEM (CEO, of the UK Sepsis trust and Global Sepsis Alliance and Clinical advisory to the WHO) had this to say:

‘‘Any system which provides earlier indications of patient deterioration than can be achieved with manual monitoring alone, could prove invaluable in the global fight against Sepsis. Not only might such systems deliver targeted notifications at the first signs of sepsis allowing much earlier treatment, but they will also allow the real time monitoring of patients' responses to treatment.

Sensium’ s recent randomised control trial has demonstrated the potential of such early warning systems, with patients in the Sensium group being treated on average 6 hours quicker than the control group in the presence of sepsis. Anything that can be done to more quickly identify and treat sepsis has to be a good thing and will lead to lives saved.”

 

The abstract summary and link to the full abstract can be found here.

‹ go back